Literature DB >> 3875367

Chemical synthesis and immunological activities of glycolipids structurally related to lipid A.

D Charon, R Chaby, A Malinvaud, M Mondange, L Szabó.   

Abstract

Complete chemical syntheses of a number of monosaccharides derived from 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-D-glucopyranose and structurally related to the hydrophobic moiety (lipid A) of several bacterial endotoxins are described. Selected humoral (complement activation) and cellular (mitogenicity and induction of interleukin 1 production) in vitro activities of a lipid A preparation obtained from the Bordetella pertussis endotoxin were compared with those of ten of these monosaccharides and with those of previously synthesized, analogous disaccharides. Results show that each of these in vitro activities of the lipid A preparation can be efficiently induced by at least one of the monosaccharide derivatives.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875367     DOI: 10.1021/bi00332a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Preexposure of mouse peritoneal macrophages to lipopolysaccharide and other stimuli enhances the nitric oxide response to secondary stimuli.

Authors:  H Fahmi; P Ancuta; S Perrier; R Chaby
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

Review 2.  Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors:  A G Johnson
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

3.  Endotoxin-induced desensitization of mouse macrophages is mediated in part by nitric oxide production.

Authors:  H Fahmi; D Charon; M Mondange; R Chaby
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

4.  Inability of pyrogenic, purified Bordetella pertussis lipid A to induce interleukin-1 release by human monocytes.

Authors:  M Caroff; J M Cavaillon; C Fitting; N Haeffner-Cavaillon
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.